We got some good news from a few of our currently featured stocks this morning in Patriot One Technologies Inc. (OTCQB : PTOTF) (TSE: PAT.V) and Azincourt Uranium Inc. (OTCBB: AZURF) (TSE: AAZ.V) and Biotricity, Inc. (OTCQB: BTCY). Prior to the open this morning, Patriot One Technologies Inc. announced an exciting reseller agreement with Information Technology Communications contracting firm JJB Federal LLC and its specialty sales division UnitedEye Inc., based in the Washington, DC area. Patriot One CEO Martin Cronin said, "We are pleased to have entered into a reseller agreement with JJB Federal, a highly credible industry partner. With today's announcement, and in just four weeks since our launch in Las Vegas, we have now achieved a number of contractual commitments totaling over $1.1 million USD. Access to government and military contracts require years of experience and an established network of contacts in any region; Washington DC is particularly unique and complex. The JJB Federal team has the connections, reach and proven experience to accelerate Patriot One product sales. We are delighted to welcome JJB Federal to our growing sales network, and to help protect the public and those who serve." I strongly suggest if you either own shares in PTOTF or are thinking about owning them, you read the PR in its entirety here: https://finance.yahoo.com/news/correction-patriot-one-obtains-purchase-141243482.html. We continue to think Patriot One is a Company with tremendous potential, and this morning's PR confirms the Company appears to be positioning itself on the right track toward revenue visibility in the foreseeable future. Although its potential has yet to be reflected in its share price, it just goes to show not all stocks trade immediately in tandem with their developing fundamental events. However, if you're willing to read between the lines from time-to-time, this is where opportunity can often arise. There's no doubt shares of PTOTF have traded lower in recent weeks, but we've pointed out on several occasions the stock could be in the process of putting in a bottom right around where it's trading now, so rather than chase a potential growth stock higher, wouldn't it be better to own it before it does? Azincourt Uranium Inc. (OTCBB: AZURF) (TSE: AAZ.V) Reveals Uranium Exploration Plans Then, Azincourt Uranium Inc. also revealed plans detailing its upcoming exploration work program at its East Preston Project located in the highly prospective western Athabasca basin ("East Preston Project"). The proposed work program is expected to commence this summer or early fall and is aimed at generating new drill targets within previously untested corridors and refining additional targets along the previously identified Swoosh corridor. You can read the Company's release in its entirety here: https://finance.yahoo.com/news/azincourt-uranium-announces-east-preston-120000630.html. Additionally, Skyharbour Resources Ltd. (OTCQB: SYHBF) (TSE SYH.V), a much more followed uranium play here in the U.S., also announced this morning an expanded view of its Company`s option partner in Azincourt Uranium outlining the same plans. You can view their PR in its entirety here: https://finance.yahoo.com/news/skyharbour-option-partner-azincourt-announces-123101002.html. The bottom line is although investing in any junior miner can often be a risky proposition, when they deliver the results are tremendous - and as you can tell by both of these uranium mining plays, it clearly would appear both are strongly convinced they'll meet their mining goals in what has already proven to be a hugely successful uranium mining area - as a matter of fact, one of the few biggest in recent history. And with uranium prices having woken up in a big way late last year, it seems the potential for both of these companies could pay investors big dividends if and when they hit their desired drilling goals. Biotricity, Inc. (OTCQB: BTCY) Establishes Panel of Industry Experts for Growth Lastly, Biotricity, Inc., the medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions that we've been talking about for quite some time, has formulated a panel of industry experts to help advise and develop guidelines for post-diagnostic cardiac care. The panel is comprised of Global to Local's research and innovation arm, faculty members from the Cumming School of Medicine at the University of Calgary, and members of Biotricity's medical advisory board. The recommendations developed by the panel will serve as the basis for a suite of chronic care monitoring solutions and as an enhancement for Biotricity's Bioflux product which is awaiting its second and final FDA 510(K). Biotricity founder and CEO Waqaas Al-Siddiq commented, "The Company is incredibly excited about kicking off this initiative. Understanding and reviewing post-diagnostic cardiac care is an important step for Biotricity as we prepare to commercialize our first medical solution, explore other chronic disease areas, and help drive awareness around the Company and our remote medical monitoring solutions." You can read the PR in its entirety here: https://finance.yahoo.com/news/biotricity-brings-together-industry-experts-120000225.html. This once again proves investors in small stocks should not only follow the news of developing companies like Biotricity, they should consider owning them when the stock in question has somewhat quieted down, because when one looks at where shares of BTCY was just a few months back, it becomes quite apparent the best time to own them is when nobody seems to care. Although BTCY has been moving quietly higher in recent weeks, should the Company end up putting it altogether and get its second and final FDA 510(K) approval, its current share price of $2.90 per share may well end up being a gift when it's all said and done. The reality is when it comes to investing in small stocks, traders and investors are far better off playing contrarian, at least that's my own personal opinion. Too often, they chase the wrong stocks higher, and leave the better ones alone simply because they're not making big runs yet. However, be rest assured if you do your diligence and you're willing to step in when nobody else is paying attention, that's when you just might catch lightening in a bottle.